XBI icon

SPDR S&P Biotech ETF

632 hedge funds and large institutions have $7.94B invested in SPDR S&P Biotech ETF in 2021 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 224 increasing their positions, 184 reducing their positions, and 72 closing their positions.

Holders
632
Holders Change
-28
Holders Change %
-4.24%
% of All Funds
11.1%
Holding in Top 10
20
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+17.65%
% of All Funds
0.35%
New
55
Increased
224
Reduced
184
Closed
72
Calls
$1.5B
Puts
$3.28B
Net Calls
-$1.77B
Net Calls Change
-$796M
Name Market Value Shares Shares
Change
Shares
Change %
FFG
701
Ford Financial Group
California
-38 Closed
SB
702
Strategic Blueprint
Georgia
-25 Closed
FPW
703
Flagship Private Wealth
Massachusetts
-10 Closed
BC
704
Burleson & Co
California
-5 Closed
CL
705
CSS LLC
Illinois
IMC Chicago
706
IMC Chicago
Illinois
IC
707
Ikarian Capital
Texas
OSAM
708
O'Shaughnessy Asset Management
Connecticut
NCM
709
Nantahala Capital Management
Connecticut
HNB
710
Huntington National Bank
Ohio
GTC
711
Ghost Tree Capital
New York
Walleye Trading
712
Walleye Trading
New York
CIM
713
Cowen Investment Management
New York
Holocene Advisors
714
Holocene Advisors
New York
ACM
715
Aquilo Capital Management
California
Parallax Volatility Advisers
716
Parallax Volatility Advisers
California
$0 3
EP
717
Eversept Partners
New York
LCM
718
Laurion Capital Management
New York
Twin Tree Management
719
Twin Tree Management
Texas
DIG
720
DeepCurrents Investment Group
New York
BMCM
721
Black Maple Capital Management
Wisconsin
CM
722
Caption Management
Oklahoma
Balyasny Asset Management
723
Balyasny Asset Management
Illinois
APM
724
Avidity Partners Management
Texas
FAIM
725
Financial Advocates Investment Management
Washington